Sanjivani Paranteral Limited (BOM:531569)

Market Cap	2.79B
Revenue (ttm)	647.81M
Net Income (ttm)	71.66M
Shares Out	11.88M
EPS (ttm)	5.54
PE Ratio	42.41
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	17,628
Average Volume	4,191
Open	238.00
Previous Close	230.75
Day's Range	222.20 - 239.00
52-Week Range	167.25 - 396.95
Beta	-0.53
RSI	46.45
Earnings Date	May 12, 2025

About Sanjivani Paranteral

Sanjivani Paranteral Limited operates as a pharmaceutical company in India. It manufactures pharmaceutical products in a form of oral solids, small volume parenteral, and sterile powder formulations for various therapeutic areas comprising central nervous system, cardiovascular system, antibiotics, gastroenterological, anti-diabetics, and anti-allergic. It also offers soft gels, topicals, nasal sprays, liquid injection, capsules, tablets, dry syrups, and ear/eye drops. The company also exports its products. Sanjivani Paranteral Limited was inco...

• Industry: Pharmaceutical Preparations
• Founded: 1994
• Employees: 33
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 531569

Financial Performance

In 2023, Sanjivani Paranteral's revenue was 544.11 million, an increase of 53.31% compared to the previous year's 354.92 million. Earnings were 61.65 million, an increase of 36.65%.